This study involves Ritlecitinib, a medicine being tested for several conditions including Alopecia Areata, which is a condition that causes hair loss in patches, Rheumatoid Arthritis, which is a disease where the body’s immune system attacks the joints causing pain and swelling, Vitiligo, which is a condition that causes loss of skin color in patches, Ulcerative Colitis, which is a disease that causes inflammation and sores in the lining of the large intestine, and Crohn’s Disease, which is a condition that causes inflammation of the digestive tract. The medicine comes in the form of a hard capsule that can be taken by mouth. The study will look at how the body absorbs the medicine when the capsule contents are sprinkled on different foods compared to when the capsule is swallowed whole.
The purpose of this study is to measure how much of the medicine gets into the bloodstream when the capsule is opened and sprinkled on applesauce, strawberry jam, or yoghurt compared to swallowing the capsule whole without food, and also to see how eating food affects the amount of medicine that gets into the bloodstream when the capsule is swallowed whole. This information is important for understanding different ways the medicine can be taken, especially for people who may have difficulty swallowing capsules. The study will involve healthy adult participants who will receive a 30 mg dose of the medicine in different ways during the study.
Participants will take part in a study where they will receive the medicine in different forms on different occasions, allowing researchers to compare how the body processes the medicine under various conditions. Blood samples will be collected to measure the amount of medicine in the bloodstream over time. The study will monitor participants for any unwanted effects that may occur during the treatment period.



Belgium